| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3850473 | American Journal of Kidney Diseases | 2010 | 12 Pages |
Abstract
Unlike previous studies of hemodialysis patients, alendronate did not decrease the progression of vascular calcification compared with placebo in patients with CKD during 18 months.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Nigel D. MBBS, FRACP, PhD, Kenneth K. MBBS, FRANZCR, Boyd J. MBBS, FRACP, PhD, Kevan R. MBChB, FRACP, PhD, Peter G. MBBS, FRACP, PhD,